Glaukos (GKOS) Interest Coverage Ratio Growth (1y) (2015 - 2026)
Glaukos (GKOS) Interest Coverage Ratio Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | -71.56% |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 68.09% |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 28.95% |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 34.84% |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 12.01% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -29.36% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 16.91% |
| 10 | Glaukos | 10.83 Bn | 10.71 Bn | 151.59 Mn | 39.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 83.83% |
| Mar 31, 2026 | 81.55% |
| Dec 31, 2025 | -569.30% |
| Sep 30, 2025 | 38.24% |
| Jun 30, 2025 | 29.55% |
| Mar 31, 2025 | 46.68% |
| Dec 31, 2024 | -174.69% |
| Sep 30, 2024 | -194.22% |
| Jun 30, 2024 | -244.50% |
| Mar 31, 2024 | -299.14% |
| Dec 31, 2023 | 8.27% |
| Sep 30, 2023 | -68.72% |
| Jun 30, 2023 | -2.96% |
| Mar 31, 2023 | -538.61% |
| Dec 31, 2022 | 532.09% |
| Sep 30, 2022 | -341.50% |
| Jun 30, 2022 | -218.42% |
| Mar 31, 2022 | 202.19% |
| Dec 31, 2021 | -436.95% |
| Sep 30, 2021 | 118.72% |